학술논문
Repeated bone targeted therapy for hormone-refractory prostate carcinoma: Randomized phase II trial with the new, high-energy radiopharmaceutical Rhenium-188 HEDP: P967
Document Type
Academic Journal
Author
Source
Onkologie. Oct 01, 2003 26 Suppl 5:200-200
Subject
Language
English
ISSN
0378-584X